1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Davide Leone & Partners Investment Co Ltd. Buys The Medicines Co, Allergan PLC, Tiffany, Sells Altaba Inc, Celgene Corp, Sprint Corp

Investment company Davide Leone & Partners Investment Co Ltd. (Current Portfolio) buys The Medicines Co, Allergan PLC, Tiffany, HP Inc, Qiagen NV, sells Altaba Inc, Celgene Corp, Sprint Corp, Biogen Inc, BlackBerry during the 3-months ended 2019Q4, according to the most recent filings of the investment company, Davide Leone & Partners Investment Co Ltd.. As of 2019Q4, Davide Leone & Partners Investment Co Ltd. owns 14 stocks with a total value of $751 million. These are the details of the buys and sells.

For the details of Davide Leone & Partners Investment Co Ltd.'s stock buys and sells, go to https://www.gurufocus.com/guru/davide+leone+%26+partners+investment+co+ltd./current-portfolio/portfolio

These are the top 5 holdings of Davide Leone & Partners Investment Co Ltd.
  1. The Medicines Co (MDCO) - 1,146,192 shares, 12.96% of the total portfolio. New Position
  2. Allergan PLC (AGN) - 506,100 shares, 12.88% of the total portfolio. New Position
  3. AT&T Inc (T) - 2,256,331 shares, 11.74% of the total portfolio.
  4. The Medicines Co (MDCO) - 1,000,000 shares, 11.31% of the total portfolio.
  5. Tiffany & Co (TIF) - 571,312 shares, 10.16% of the total portfolio. New Position
New Purchase: The Medicines Co (MDCO)

Davide Leone & Partners Investment Co Ltd. initiated holding in The Medicines Co. The purchase prices were between $49.68 and $84.94, with an estimated average price of $67.5. The stock is now traded at around $84.90. The impact to a portfolio due to this purchase was 12.96%. The holding were 1,146,192 shares as of .

New Purchase: Allergan PLC (AGN)

Davide Leone & Partners Investment Co Ltd. initiated holding in Allergan PLC. The purchase prices were between $165.4 and $191.58, with an estimated average price of $180.86. The stock is now traded at around $198.32. The impact to a portfolio due to this purchase was 12.88%. The holding were 506,100 shares as of .

New Purchase: Tiffany & Co (TIF)

Davide Leone & Partners Investment Co Ltd. initiated holding in Tiffany & Co. The purchase prices were between $86.63 and $133.8, with an estimated average price of $119.09. The stock is now traded at around $134.27. The impact to a portfolio due to this purchase was 10.16%. The holding were 571,312 shares as of .

New Purchase: HP Inc (HPQ)

Davide Leone & Partners Investment Co Ltd. initiated holding in HP Inc. The purchase prices were between $16.03 and $20.69, with an estimated average price of $18.99. The stock is now traded at around $22.37. The impact to a portfolio due to this purchase was 5.47%. The holding were 2,000,000 shares as of .

New Purchase: Qiagen NV (QGEN)

Davide Leone & Partners Investment Co Ltd. initiated holding in Qiagen NV. The purchase prices were between $25.41 and $43.1, with an estimated average price of $35.32. The stock is now traded at around $37.14. The impact to a portfolio due to this purchase was 4.54%. The holding were 1,010,107 shares as of .

Added: Vertex Pharmaceuticals Inc (VRTX)

Davide Leone & Partners Investment Co Ltd. added to a holding in Vertex Pharmaceuticals Inc by 62.44%. The purchase prices were between $166.71 and $223.91, with an estimated average price of $203.47. The stock is now traded at around $243.82. The impact to a portfolio due to this purchase was 1.39%. The holding were 124,358 shares as of .

Sold Out: Altaba Inc (AABA)

Davide Leone & Partners Investment Co Ltd. sold out a holding in Altaba Inc. The sale prices were between $19.63 and $19.63, with an estimated average price of $19.63.

Sold Out: Celgene Corp (CELG)

Davide Leone & Partners Investment Co Ltd. sold out a holding in Celgene Corp. The sale prices were between $97.62 and $110.41, with an estimated average price of $105.2.

Sold Out: Sprint Corp (S)

Davide Leone & Partners Investment Co Ltd. sold out a holding in Sprint Corp. The sale prices were between $5.19 and $6.48, with an estimated average price of $5.85.

Sold Out: Biogen Inc (BIIB)

Davide Leone & Partners Investment Co Ltd. sold out a holding in Biogen Inc. The sale prices were between $220.06 and $304.07, with an estimated average price of $279.04.



Here is the complete portfolio of Davide Leone & Partners Investment Co Ltd.. Also check out:

1. Davide Leone & Partners Investment Co Ltd.'s Undervalued Stocks
2. Davide Leone & Partners Investment Co Ltd.'s Top Growth Companies, and
3. Davide Leone & Partners Investment Co Ltd.'s High Yield stocks
4. Stocks that Davide Leone & Partners Investment Co Ltd. keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)